|

Tacabrutideg Clinical Trials

6 actively recruiting trials across 4 locations

▲ +1 trial since September 2026

Also known as: BGB-16673

Pipeline

Phase 2: 1Phase 3: 2Phase 1/2: 3

Top Sponsors

  • BeOne Medicines5
  • Massachusetts General Hospital1

Indications

  • Cancer6
  • Chronic Lymphocytic Leukemia4
  • B-cell Malignancy3
  • Waldenström Macroglobulinemia2
  • Small Lymphocytic Lymphoma2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.